o morzu BEZ CENZURY! - opinie internautów

[thomassins]

COPD, or Chronic Obstructive Pulmonary Disease, is a progressive lung disease that makes it hard to breathe. The main cause of COPD is smoking, but other causes include exposure to secondhand smoke, air pollution, and dust. COPD is a serious health problem that can lead to death.

COPD is a progressive lung disease that makes it hard to breathe. The main cause of COPD is smoking, but other causes include exposure to secondhand smoke, air pollution, and dust. COPD is a serious health problem that can lead to death.

Breo Ellipta is a prescription medication used to treat asthma and COPD. It is a combination of two drugs, fluticasone and vilanterol. Fluticasone is a steroid that reduces inflammation in the airways. Vilanterol is a long-acting beta-agonist that opens up the airways.


The price tag on Breo Ellipta might make you do a double-take. After all, this inhaler medication only contains fluticasone furoate and vilanterol, two drugs that are readily available in other inhalers at a fraction of the cost. So, what gives? Why is Breo Ellipta so expensive

The answer, in short, is that Breo Ellipta is a brand-name drug, and brand-name drugs tend to be more expensive than their generic counterparts. But there are a few other factors at play here, too. Let's take a closer look.

For one, Breo Ellipta is a combination medication, meaning it contains two drugs in one inhaler. This makes it more convenient than having to use two separate inhalers, which could be a big selling point for some people.

Secondly, Breo Ellipta is a newer medication, and newer drugs are often more expensive than older ones. This is because it takes a lot of money and time to bring a new drug to market, and drug companies typically recoup these costs by charging more for the medication.

[Esmirrasnda]

A brand-name inhaled drug called Breo Ellipta is used to treat chronic obstructive pulmonary disease (COPD), letter boxed which encompasses both chronic bronchitis and emphysema, and asthma on a long-term maintenance basis.

[sakobiy]

The soaring cost of Breo Ellipta, a medication vital for managing chronic respiratory conditions, raises concerns and queries about accessibility. Factors contributing to its steep pricing include patented technology, research and development costs, and market exclusivity. However, as discussions about medication costs intensify, attention also shifts towards exploring alternative and cost-effective healthcare options. This includes delving into homeopathic lyme disease treatments and holistic health practices, highlighting the importance of a comprehensive approach to healthcare. While the affordability of essential medications remains a concern, fostering conversations that encompass both conventional and alternative remedies encourages a more holistic view of accessible and affordable healthcare solutions.

[AshtonHorrocks]

The soaring cost of Breo Ellipta, a widely prescribed inhaler for respiratory conditions like COPD and asthma, is primarily attributed to a multitude of factors, among which lies the intricate network of medical equipment distributors. The complex supply chain involving these distributors significantly influences the final retail price. Additionally, patent protection and limited competition contribute to the sustained high cost of this medication. The intricate distribution network, marked by intermediary parties and logistical complexities, amplifies the overall expense, posing challenges in reducing the financial burden on patients reliant on this crucial medication.